A prediction model for lung cancer diagnosis that integrates genomic and clinical features

Cancer Prevention Research

Volumn 1, Issue 1, 2008, Pages 56-64

  Beane, Jennifer ^a,b   Sebastiani, Paola ^c   Whitfield, Theodore H ^d   Steiling, Katrina ^a   Dumas, Yves Martine ^a   Lenburg, Marc E ^a,b,e   Spira, Avrum ^a,b  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b Bioinformatics Program   (United States)

^c BOSTON UNIVERSITY   (United States)

^d Biostatistics Solutions Consulting   (United States)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

ADULT; AGED; ALGORITHM; ARTICLE; CARCINOMA; CLINICAL TRIAL; COHORT ANALYSIS; EVALUATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; GENOMICS; HUMAN; LUNG TUMOR; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PROGNOSIS; RESPIRATORY TRACT MUCOSA; STATISTICAL MODEL;

ADULT; AGED; ALGORITHMS; CARCINOMA; COHORT STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOMICS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PROGNOSIS; RESPIRATORY MUCOSA; TUMOR MARKERS, BIOLOGICAL;

EID: 52649131476     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-08-0011     Document Type: Article

References (28)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Shields PG. Molecular epidemiology of lung cancer. Ann Oncol 1999;10 Suppl 5:S7-11.
3. Hoffman PC, Mauer AM, Vokes EE. Lung cancer. Lancet 2000;355:479-85.
4. Postmus PE. Bronchoscopy for lung cancer. Chest 2005;128:16-8.
5. Mazzone P, Jain P, Arroliga AC, Matthay RA. Bronchoscopy and needle biopsy techniques for diagnosis and staging of lung cancer. Clin Chest Med 2002;23:137-58, ix.
6. Schreiber G, McCrory DC. Performance characteristics of different modalities for diagnosis of suspected lung cancer: summary of published evidence. Chest 2003;123:115-28S.
7. Spira A, Beane JE, Shah V, et al. Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer. Nat Med 2007;13:361-6.
8. Pittman J, Huang E, Dressman H, et al. Integrated modeling of clinical and gene expression information for personalized prediction of disease outcomes. Proc Natl Acad Sci U S A 2004;101:8431-6.
9. Li L. Survival prediction of diffuse large-B-cell lymphoma based on both clinical and gene expression information. Bioinformatics 2006;22:466-71.
10. Stephenson AJ, Smith A, Kattan MW, et al. Integration of gene expression profiling and clinical variables to predict prostate carcinoma recurrence after radical prostatectomy. Cancer 2005; 104:290-8.
11. West M, Ginsburg GS, Huang AT, Nevins JR. Embracing the complexity of genomic data for personalized medicine. Genome Res 2006;16: 559-66.
12. McWilliams A, Lam S. New approaches to lung cancer prevention. Curr Oncol Rep 2002;4:487-94.
13. Trunk G, Gracey DR, Byrd RB. The management and evaluation of the solitary pulmonary nodule. Chest 1974;66:236-9.
14. Thurston SW, Liu G, Miller DP, Christiani DC. Modeling lung cancer risk in case-control studies using a new dose metric of smoking. Cancer Epidemiol Biomarkers Prev 2005;14:2296-302.
15. Gurney JW. Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part I. Theory. Radiology 1993; 186:405-13.
16. Mannino DM, Aguayo SM, Petty TL, Redd SC. Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up. Arch Intern Med 2003;163:1475-80.
17. Wahidi MM, Govert JA, Goudar RK, Gould MK, McCrory DC. Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer? ACCP evidence-based clinical practice guidelines (2nd ed.). Chest 2007;132:94-107S.
18. Ung YC, Maziak DE, Vanderveen JA, et al. 18Fluorodeoxyglucose positron emission tomography in the diagnosis and staging of lung cancer: a systematic review. J Natl Cancer Inst 2007.
19. Cummings SR, Lillington GA, Richard RJ. Estimating the probability of malignancy in solitary pulmonary nodules. A Bayesian approach. Am Rev Respir Dis 1986;134:449-52.
20. Swensen SJ, Silverstein MD, Ilstrup DM, Schleck CD, Edell ES. The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Arch Intern Med 1997;157:849-55.
21. Swensen SJ, Silverstein MD, Edell ES, et al. Solitary pulmonary nodules: clinical prediction model versus physicians. Mayo Clin Proc 1999; 74:319-29.
22. Spitz MR, Hong WK, Amos CI, et al. A risk model for prediction of lung cancer. J Natl Cancer Inst 2007;99:715-26.
23. Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999;286:531-7.
24. Akaike H. A new look at the statistical model identification. IEEE Trans Automatic Control 1974; 19:716-23.
25. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143:29-36.
26. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-43.
27. Sullivan PM, Etzioni R, Feng Z, et al. Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 2001;93:1054-61.
28. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37-46.